CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients.
Nasri M, Ritter M, Mir P, Dannenmann B, Aghaallaei N, Amend D, Makaryan V, Xu Y, Fletcher B, Bernhard R, Steiert I, Hahnel K, Berger J, Koch I, Sailer B, Hipp K, Zeidler C, Klimiankou M, Bajoghli B, Dale DC, Welte K, Skokowa J.
Nasri M, et al. Among authors: dannenmann b.
Haematologica. 2020 Mar;105(3):598-609. doi: 10.3324/haematol.2019.221804. Epub 2019 Jun 27.
Haematologica. 2020.
PMID: 31248972
Free PMC article.